Nice. This is what I was expecting.
A buyout didn't make sense as they haven't been positioning for it at all. I could see a buyout in the future but it would be a big pharma co, not a fellow LP, and it will most likely be in a couple of years.
The agreement with Canntab makes complete sense. This is the PR we've been waiting for too. Everyone that believes in Emblem knows it's all about their pharmaceutical potential. This is evidence of their commitment to that direction.